1-3 of 3
Anshu Giri, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Patients with Limited-Stage Plasmablastic Lymphoma

Brian T. Hess, MD, Anshu Giri, MD, Yeonhee Park, PhD, Krina K. Patel, MD, Brian K. Link, MD, Grzegorz S. Nowakowski, MD, Seth M Maliske, MD, Sonia Fortin, Julio C. Chavez, MD, Hayder Saeed, MD, Brian T. Hill, MD, Alex V. Mejia Garcia, MD, Kami J. Maddocks, MD, Walter Hanel, MD, Nina D. Wagner-Johnston, Marcus Raymond Messmer, MD, Brad S. Kahl, MD, Marcus Watkins, PhD, Juan Pablo Alderuccio, MD, Izidore S. Lossos, MD, Sunita Nathan, MD, Victor M. Orellana-Noia, MD, Craig A. Portell, MD, Daniel J. Landsburg, MD, Emily C. Ayers, MD, Jorge J. Castillo, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-138536
Published: 2020
Journal Articles

Outcomes of Patients with Limited-Stage Aggressive Large B-Cell Lymphoma with MYC Rearrangement with and without BCL2 and/or BCL6 Rearrangements: A Retrospective Analysis from 15 US Academic Centers

Shalin K. Kothari, MD, Shaoying Li, MD, L. Jeffrey Medeiros, MD, Emily C. Ayers, MD, Daniel J. Landsburg, MD, David A. Bond, MD, Kami J. Maddocks, MD, Anshu Giri, MD, Brian T. Hess, MD, Luu Q. Pham, Ranjana Advani, MD, Yang Liu, MD, Stefan Klaus Barta, MDMRCP,MS, Julie M. Vose, MDMBA, Michael C. Churnetski, BS, Jonathon B. Cohen, MDMS, Madelyn Burkart, MD, Reem Karmali, MD, Joanna Zurko, MD, Amitkumar Mehta, MD, Adam J Olszewski, MD, Sarah S Lee, MD, Brian T. Hill, MD PhD, Timothy F. Burns, MD, Frederick Lansigan, MD, Emma Rabinovich, MD, David Peace, MD, Adrienne Groman, MS, Kris Attwood, PhD MS, Francisco J. Hernandez-Ilizaliturri, MD, Pallawi Torka, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 451.
https://doi.org/10.1182/blood-2018-99-111530
Published: 2018
Journal Articles

Outcome of Patients with Aggressive B Cell Lymphomas Who Receive Second-Line Salvage Immunochemotherapy Following Treatment Failure of Intensive First-Line Immunochemotherapy

Emily C. Ayers, MD, Shaoying Li, MD, Jeffrey Medeiros, MD, David A. Bond, MD, Kami J. Maddocks, MD, Pallawi Torka, MD, Angel Mier Hicks, MD, Madeira Curry, Nina D. Wagner-Johnston, MD, Reem Karmali, MD, Amir Behdad, MD, Bita Fakhri, MDMPH, Brad S Kahl, MD, Michael C Churnetski, BS, Jonathon B. Cohen, MDMS, Nishitha Reddy, MD, Dipenkumar Modi, MD, Radhakrishnan Ramchandren, MD, Christina Howlett, PharmD, BCOP, Lori A. Leslie, MD, Samuel Cytryn, Catherine Diefenbach, MD, Rawan Faramand, MD, Julio C. Chavez, MD, Adam J Olszewski, MD, Yang Liu, MD, Stefan Klaus Barta, MDMRCP,MS, Dhruvika Mukhija, MD, Brian T. Hill, MD PhD, Helen Ma, MD, Jennifer E Amengual, MD, Sunita Nathan, MD, Sarit Assouline, Victor M. Orellana-Noia, MD, Craig A. Portell, MD, Ashwin Chandar, MD, Kevin A. David, MD, Anshu Giri, MD, Brian T. Hess, MD, Daniel J. Landsburg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 453.
https://doi.org/10.1182/blood-2018-99-115527
Published: 2018